Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs.
J Vet Sci
; 17(3): 431-3, 2016 Sep 30.
Article
en En
| MEDLINE
| ID: mdl-26726023
ABSTRACT
Seventeen dogs were treated with L-ornithin-L-aspartate (LOLA; experimental group). Three dogs were treated with lactulose recognized therapy (control group). Following LOLA administration, 15 dogs experienced a significant decrease in ammonia level (p ï¼ 0.05) and showed clinical signs of improvement. However, there were no clinical signs of improvement in two dogs, even though the ammonia level decreased. Conversely, the clinical signs of the control group also improved and the ammonia level decreased, although these changes were not significant (p ï¼ 0.05). These results suggest that LOLA is an effective drug to treat hyperammonemia in veterinary medicine.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Encefalopatía Hepática
/
Hiperamonemia
/
Dipéptidos
/
Enfermedades de los Perros
Límite:
Animals
Idioma:
En
Año:
2016
Tipo del documento:
Article